Literature DB >> 10667915

Influence of a transmembrane protein on the permeability of small molecules across lipid membranes.

T Xiang1, B D Anderson.   

Abstract

The influence of the nonchannel conformation of the transmembrane protein gramicidin A on the permeability coefficients of neutral and ionized alpha-X-p-methyl-hippuric acid analogues (XMHA) (X = H, OCH(3), CN, OH, COOH, and CONH(2)) across egg-lecithin membranes has been investigated in vesicle efflux experiments. Although 10 mol% gramicidin A increases lipid chain ordering, it enhances the transport of neutral XMHA analogues up to 8-fold, with more hydrophilic permeants exhibiting the greatest increase. Substituent contributions to the free energies of transfer of both neutral and anionic XMHA analogues from water into the bilayer barrier domain were calculated. Linear free-energy relationships were established between these values and those for solute partitioning from water into decadiene, chlorobutane, butyl ether, and octanol to assess barrier hydrophobicity. The barrier domain is similar for both neutral and ionized permeants and substantially more hydrophobic than octanol, thus establishing its location as being beyond the hydrated headgroup region and eliminating transient water pores as the transport pathway for these permeants, as the hydrated interface or water pores would be expected to be more hydrophilic than octanol. The addition of 10 mol% gramicidin A alters the barrier domain from a decadiene-like solvent to one possessing a greater hydrogen-bond accepting capacity. The permeability coefficients for ionized XMHAs increase with Na(+) or K(+) concentration, exhibiting saturability at high ion concentrations. This behavior can be quantitatively rationalized by Gouy-Chapman theory, though ion-pairing cannot be conclusively ruled out. The finding that transmembrane proteins alter barrier selectivity, favoring polar permeant transport, constitutes an important step toward understanding permeability in biomembranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10667915     DOI: 10.1007/s002320001019

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  8 in total

1.  Independence of substituent contributions to the transport of small molecule permeants in lipid bilayers.

Authors:  P T Mayer; T X Xiang; B D Anderson
Journal:  AAPS PharmSci       Date:  2000

2.  Computer simulation of small molecule permeation across a lipid bilayer: dependence on bilayer properties and solute volume, size, and cross-sectional area.

Authors:  D Bemporad; C Luttmann; J W Essex
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

3.  Pharmacokinetic modeling to assess factors affecting the oral bioavailability of the lactone and carboxylate forms of the lipophilic camptothecin analogue AR-67 in rats.

Authors:  Eyob D Adane; Zhiwei Liu; Tian-Xiang Xiang; Bradley D Anderson; Markos Leggas
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

4.  A computer simulation of functional group contributions to free energy in water and a DPPC lipid bilayer.

Authors:  Tian-xiang Xiang; Bradley D Anderson
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

5.  Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.

Authors:  I-Jen Chen; Rajneesh Taneja; Daxu Yin; Paul R Seo; David Young; Alexander D MacKerell; James E Polli
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

Review 6.  Does transbilayer diffusion have a role in membrane transport of drugs?

Authors:  Stefan Balaz
Journal:  Drug Discov Today       Date:  2012-06-15       Impact factor: 7.851

7.  Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid.

Authors:  Johan Ulander; A D J Haymet
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

Review 8.  Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches.

Authors:  David Dahlgren; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2019-08-13       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.